Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial

BACKGROUND: To achieve the World Health Organization hepatitis C virus (HCV) elimination targets, it is essential to increase access to treatment. Direct-acting antiviral (DAA) treatment can be provided in primary healthcare services (PHCS), improving accessibility, and, potentially, retention in ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, A. J., Doyle, J. S., Gane, E., Stedman, C., Draper, B., Iser, D., Roberts, S. K., Kemp, W., Petrie, D., Scott, N., Higgs, P., Agius, P. A., Roney, J., Stothers, L., Thompson, A. J., Hellard, M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048874/
https://www.ncbi.nlm.nih.gov/pubmed/30012192
http://dx.doi.org/10.1186/s13063-018-2768-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048874/
https://www.ncbi.nlm.nih.gov/pubmed/30012192
http://dx.doi.org/10.1186/s13063-018-2768-3

Ejemplares similares